Investigator
City University of Hong Kong
Intracellular delivery of therapeutic proteins through N-terminal site-specific modification
Adopting orthogonal dual-labeling strategies, a cell-permeable RNase A prodrug was designed for ROS-responsive targeted cancer therapy.
Researcher
Scopus: 55729273500
